When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
The musician-turned-biotech-founder waiting to fundraise
Related Posts
Last 24 hours to get 50% off a second pass to TechCrunch Disrupt 2026
Last day to buy one pass and get a second one at 50% off to TechCrunch Disrupt 2026.…
Why companies like Apple are building AI agents with limits
Next-generation AI assistants being developed in the Apple ecosystem and by chipmakers like Qualcomm, but early reports suggest…
No one has a good plan for how AI companies should work with the government
As OpenAI transitions from a wildly successful consumer startup into a piece of national security infrastructure, the company…
